An Z, Yang X, Zhu Y, Zhao D, et al. Outcomes After Neoadjuvant Targeted Therapy in Patients with ALK or ROS1 Rearrangement Locally Advanced Non-small Cell Lung Cancer. Ann Surg Oncol 2025 Jul 8. doi: 10.1245/s10434-025-17767.
PMID: 40627103